Karan Bali1, Zeinab Mohamed2, Anna Scheeder1, Anna-Maria Pappa3, Susan Daniel2,4, Clemens F Kaminski1, Róisín M Owens1, Ioanna Mela1. 1. Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, U.K. 2. School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States. 3. Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates. 4. School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, United States.
Abstract
The rise of antibiotic resistance is a growing worldwide human health issue, with major socioeconomic implications. An understanding of the interactions occurring at the bacterial membrane is crucial for the generation of new antibiotics. Supported lipid bilayers (SLBs) made from reconstituted lipid vesicles have been used to mimic these membranes, but their utility has been restricted by the simplistic nature of these systems. A breakthrough in the field has come with the use of outer membrane vesicles derived from Gram-negative bacteria to form SLBs, thus providing a more physiologically relevant system. These complex bilayer systems hold promise but have not yet been fully characterized in terms of their composition, ratio of natural to synthetic components, and membrane protein content. Here, we use correlative atomic force microscopy (AFM) with structured illumination microscopy (SIM) for the accurate mapping of complex lipid bilayers that consist of a synthetic fraction and a fraction of lipids derived from Escherichia coli outer membrane vesicles (OMVs). We exploit the high resolution and molecular specificity that SIM can offer to identify areas of interest in these bilayers and the enhanced resolution that AFM provides to create detailed topography maps of the bilayers. We are thus able to understand the way in which the two different lipid fractions (natural and synthetic) mix within the bilayers, and we can quantify the amount of bacterial membrane incorporated into the bilayer. We prove the system's tunability by generating bilayers made using OMVs engineered to contain a green fluorescent protein (GFP) binding nanobody fused with the porin OmpA. We are able to directly visualize protein-protein interactions between GFP and the nanobody complex. Our work sets the foundation for accurately understanding the composition and properties of OMV-derived SLBs to generate a high-resolution platform for investigating bacterial membrane interactions for the development of next-generation antibiotics.
The rise of antibiotic resistance is a growing worldwide human health issue, with major socioeconomic implications. An understanding of the interactions occurring at the bacterial membrane is crucial for the generation of new antibiotics. Supported lipid bilayers (SLBs) made from reconstituted lipid vesicles have been used to mimic these membranes, but their utility has been restricted by the simplistic nature of these systems. A breakthrough in the field has come with the use of outer membrane vesicles derived from Gram-negative bacteria to form SLBs, thus providing a more physiologically relevant system. These complex bilayer systems hold promise but have not yet been fully characterized in terms of their composition, ratio of natural to synthetic components, and membrane protein content. Here, we use correlative atomic force microscopy (AFM) with structured illumination microscopy (SIM) for the accurate mapping of complex lipid bilayers that consist of a synthetic fraction and a fraction of lipids derived from Escherichia coli outer membrane vesicles (OMVs). We exploit the high resolution and molecular specificity that SIM can offer to identify areas of interest in these bilayers and the enhanced resolution that AFM provides to create detailed topography maps of the bilayers. We are thus able to understand the way in which the two different lipid fractions (natural and synthetic) mix within the bilayers, and we can quantify the amount of bacterial membrane incorporated into the bilayer. We prove the system's tunability by generating bilayers made using OMVs engineered to contain a green fluorescent protein (GFP) binding nanobody fused with the porin OmpA. We are able to directly visualize protein-protein interactions between GFP and the nanobody complex. Our work sets the foundation for accurately understanding the composition and properties of OMV-derived SLBs to generate a high-resolution platform for investigating bacterial membrane interactions for the development of next-generation antibiotics.
In 2019, the World
Health Organization declared that antimicrobial
resistance is one of the 10 greatest threats to global health.[1] A vast majority of antimicrobial-resistant strains
of bacteria such as Escherichia coli, Pseudomonas
aeruginosa, and Acinetobacter baumanii belong
to the Gram-negative class of bacteria. Especially concerning is the
prevalence of multidrug resistant strains of these bacteria; for instance,
17% of E. coli strains have been found to be multidrug
resistant.[2] In the search for novel strategies
for combating these bacterial strains, it is crucial to precisely
determine the events occurring at the level of the cell membrane,
the outer membrane in the case of Gram-negative bacteria, the primary
site of any interaction with the external environment. Reproduction
of the in vivo cell membrane environment through
the development of artificial lipid bilayers will reveal these crucial
interactions.Supported lipid bilayers (SLBs) made from reconstituted
lipid vesicles
are important tools in molecular biology, especially in the study
of biological processes at the cellular or subcellular level. However,
efforts to deepen our understanding of these processes in physiologically
relevant environments are hampered by the simple nature of these bilayers.
One approach to introducing physiologically relevant features into
SLBs is the reconstitution of purified membrane proteins into proteoliposomes
and the subsequent formation of SLBs from these proteoliposomes. This
method has been used in several studies, including the study of protein–protein
interactions,[3] membrane–protein
interactions and membrane remodeling,[4−6] membrane poration,[7] host–pathogen interactions,[8] single-receptor activation,[9] etc. Nevertheless, the method of purifying and reconstituting
transmembrane proteins requires protein denaturing and refolding in
the presence of detergents, which leads to low throughput and reproducibility
issues. There is also a lack of control over protein orientation in
the bilayers.[10]A breakthrough in
the field has come through the use of vesicles
derived from cell membranes to form SLBs,[11] and this can be applied specifically to creating Gram-negative outer
membrane models. Gram-negative bacteria naturally produce vesicles
that contain components of the outer membrane, known as outer membrane
vesicles (OMVs). OMVs are 20–250 nm in diameter and are known
to function in roles ranging from quorum sensing and signaling to
horizontal gene transfer, all of which are important for bacterial
communication and survival. OMVs can be easily isolated and harvested
from bacteria through a series of centrifugation steps.[12] By inducing OMVs to rupture and fuse with the
addition of synthetic liposomes, one can generate outer membrane SLBs
(OM-SLBs) that faithfully represent a naturally occurring outer membrane.[13] These bilayers, which contain both bacterial
and synthetic lipid fractions, have been shown to retain components
such as outer membrane proteins and lipopolysaccharides in the correct
orientation.[14] Therefore, the system retains
physiological properties that are beneficial to the investigation
of protein–protein interactions, protein–ligand interactions,
and other lipid membrane properties in vitro. Additionally,
because these membrane models do not use live cells, they are much
safer when investigating pathogenic bacterial membrane interactions.
These complex bilayer systems hold promise but have not yet been fully
characterized in terms of their composition and membrane protein content.
Here, we use correlative microscopy to characterize the structural
and functional properties of OM-SLBs at the nanoscale, in levels of
detail that conventional microscopy methods cannot attain.To
visualize OM-SLBs, we combined atomic force microscopy (AFM)
with structured illumination microscopy (SIM). AFM permits the direct
observation of SLBs and proteins bound to them at high resolution
(∼10 nm).[15] However, AFM is a label-free
technique and is thus incapable of identifying specific proteins of
interest in lipid bilayers. Super-resolution microscopy techniques,
such as SIM, enable visualization of specific molecules of interest
through staining but at resolution lower than that of AFM.[16] Here, we combine AFM with SIM to overcome the
limitations of the two techniques and visualize OM-SLBs with high
resolution and specificity.
Experimental Section
Growth
of Bacterial Cultures and Isolation of OMVs
Five milliliters
of liquid Luria-Bertani (LB) broth was inoculated
with E. coli BL21(DE3) (Invitrogen) cells and grown
for 16–20 h. Two milliliters of the overnight culture was added
to 200 mL of LB broth and allowed to incubate at 37 °C for ∼3
h until the OD600 of the culture was ∼1.5. The culture
was then centrifuged (4000g, 4 °C) for 15 min
to remove cell debris, and the supernatant was collected. The supernatant
was further passed through a 0.22 μm filter. The outer membrane
vesicles (OMVs) were then isolated by ultracentrifugation (140000g, 4 °C) for 3 h (Beckman Coulter, type 50.2 Ti fixed-angle
rotor), and the pellets were resuspended in 250 μL of phosphate-buffered
saline (PBS) supplemented with a 2 mM MgCl2 solution. Finally,
the OMV solution was centrifuged (16000g, 4 °C)
for 30 min to remove any final contaminants such as flagella. The
supernatant was collected and resuspended in 500 μL of PBS supplemented
with a 2 mM MgCl2 solution. The final OMV solutions were
then stored at −80 °C for further experiments.
Preparation
of Synthetic Liposomes
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho(1′-rac-glycerol)
(POPG), purchased from Avanti Polar Lipids and stored in a chloroform
solution at −20 °C, was used to prepare synthetic lipid
liposomes. A nitrogen stream was used to evaporate the chloroform,
and the sample was further desiccated for 1 h in a vacuum. The lipids
were then hydrated in PBS supplemented with 2 mM MgCl2 to
give a final lipid concentration of 4 mg/mL. Single unilamellar vesicles
were made by lipid extrusion through a 50 nm pore polycarbonate membrane,
and samples were stored for up to 2 weeks at 4 °C.
Formation of
Supported Lipid Bilayers on Glass Coverslips
Glass coverslips
(Academy, 22 mm × 40 mm, 0.16–0.19
mm thick) were first cleaned with acetone and isopropanol before being
functionalized by incubation with a poly-l-lysine solution
[0.1% (w/v)] for 15 min. The PLL solution was washed away with deionized
H2O before 100 μL of ∼1010 OMVs/mL
was added to the glass slide. The OMVs were allowed to incubate for
20 min before being washed twice with a PBS solution to remove excess
unadhered OMVs; 100 μL of the synthetic lipid vesicles was then
added for 1 h to induce rupturing of the OMVs. The well was then washed
again twice with PBS, and finally 30% PEG was added for 10 min as
a final SLB formation step. The SLBs were then kept in a PBS solution
for imaging. For experiments involving only synthetic lipid bilayers,
the same protocol was followed without the first OMV incubation step.
Characterization of SLBs Using Fluorescence Recovery after Photobleaching
(FRAP)
Prior to analysis by fluorescence recovery after photobleaching
(FRAP), OMVs must be fluorescently labeled. This was achieved by adding
1 μL of octadecyl rhodamine chloride-18 (R18) dye (Invitrogen)
to 200 μL of the OMV solution and sonicating for 15 min. A G25
spin column (GE Healthcare) was used to remove unbound/excess R18
by centrifugation at 3000 rpm for 3 min at room temperature. Lipid
bilayers were formed using the protocol outlined above.FRAP
measurements were conducted using an inverted Zeiss LSM800 confocal
microscope with a 10× objective lens. A 30 μm diameter
bleaching spot was made, and recovery of the fluorescence intensity
of this spot was measured over time relative to a 50 μm diameter
reference spot. The data were analyzed using MATLAB, and the fluorescence
recovery was modeled using a modified Bessel function as described
by Soumpasis et al.[17] The model fit was
used to extract the diffusion coefficient (D) according
to the equation D = r2/4τ, where r is the radius of the photobleached
spot and τ is the characteristic diffusion time. The fit was
also used to extract the mobile fraction (MF) according to the terms
(IE – I0)/(II – I0), where IE is the final postbleach
intensity value, I0 is the first postbleach
intensity value, and II is the initial
prebleach intensity value.
Production of OMVs Expressing the Lpp-OmpA-GFP
Binding Nanobody
The pK:LppOmpA-NB plasmid was kindly provided
by M. Norholm (Technical
University of Denmark) and transformed into E. coli BL21(DE3) cells as described previously.[18] To express the protein in OMVs, OMVs were grown in the same manner
as described above except that 5 mM rhamnose was added to the bacterial
culture at an OD of ∼0.3 to induce nanobody expression. The
culture was then grown for a further 5 h after induction to ensure
nanobody OMV production.
GFP Binding Assays for OM SLBs
Bilayers
were formed
by the process described previously and incubated with a 0.06 mg/mL
GFP solution (Sino Biological) for 30 min at 30 °C. The incubation
was stopped by removing the GFP solution and washing with PBS buffer
three times before imaging.
Correlative AFM/SIM and Data Analysis
Correlative AFM–SIM
imaging was performed by combining a Bioscope Resolve system (Bruker)
with a custom-built SIM system. The piezo stage of the SIM microscope
was removed from the inverted microscope frame, and the stage of the
AFM system was used to drive both microscopes at the same time. An
image of the setup is shown in Figure S5. The stage of the specific AFM system is designed so that the sample
holder allows for optical detection of specimens from below, while
the AFM scanning head can access the sample from above. The fields
of view (FOVs) of the two microscopes were aligned so that the AFM
probe was positioned in the middle of the FOV of the SIM microscope,
by carefully moving the AFM stage using the alignment knobs. The final,
fine alignment was achieved by using a bright-field image of the “shadow”
of the AFM cantilever, taken with the SIM, to precisely align the
AFM probe with the SIM lens (Figure S6).To acquire structured illumination microscopy images, a 60×/1.2
NA water immersion lens (UPLSAPO 60XW, Olympus) focused the structured
illumination pattern onto the sample, and the same lens was also used
to capture the fluorescence emission light before imaging onto an
sCMOS camera (C11440, Hamamatsu). The wavelengths used for excitation
were 561 nm (OBIS 561, Coherent) for the lipid bilayers and 488 nm
(iBEAM-SMART-488, Toptica) for the GFP. Images were acquired using
customized SIM software described previously.[19]AFM images were acquired in Scanasyst mode using ScanasystFluid+
probes (Bruker), with a nominal spring constant of 0.7 N m–1 and a resonant frequency of 150 kHz. Images were recorded at scan
speeds of 1.5 Hz and tip–sample interaction forces between
200 and 300 pN. Large-scale images (20 μm × 20 μm)
were used to register the AFM with the SIM FOVs, and small (2 μm
× 2 μm) scans were performed to better resolve the morphology
of the bilayers. Raw AFM images were first order fitted with reference
to the lipid bilayer. Height measurements on the bilayers were performed
by taking cross sections across different areas of interest, using
the Nanoscope analysis software (Bruker).For quantification
of the bacterial component in the bilayers,
AFM micrographs were converted into eight-bit images using Fiji (ImageJ)
and thresholded to the height of the synthetic bilayer component.
The area covered by the bacterial component (above the threshold)
was calculated using the inbuilt area measurement tool in Fiji.
Results and Discussion
Our strategy for generating bacterial
OMV-derived lipid bilayers
is depicted in Figure a. We grew E. coli BL21(DE3) from an overnight culture
and isolated OMVs as described in the Experimental
Section. The dynamic light scattering (DLS) measurements showed
an average hydrodynamic size of 101 ± 3 nm, which lies within
the size range of OMVs. This was further confirmed by nanoparticle
tracking analysis (NTA), a more precise method of size determination
compared to DLS because DLS measures fluctuations in scattering intensity
from a sample as a whole whereas NTA allows the diffusion of individual
particles to be tracked.[20,21] This method identified
the main subpeaks at 88 and 152 nm (Figure S1). The concentration of vesicles measured with NTA was ∼1011 particles/mL. Transmission electron microscopy was used
to directly visualize the OMVs and showed that the vesicles were spherical
with diameters in the size range determined by DLS and NTA (Figure S1). Moreover, the vesicles retain the
natural composition of the outer membrane, including outer membrane
proteins that are involved in a variety of important processes. We
confirmed the presence of the membrane protein OmpC, which is involved
in the transport of antibiotics and small molecules across the membrane
as well as acting as a binding site for the T4 bacteriophage,[22,23] by a dot blot assay (Figure S2).
Figure 1
OM-SLB formation
and fluorescence microscopy analysis. (a) Schematic
showing the process of forming OM-SLBs on PLL-coated coverslips. OMVs
are produced naturally by E. coli and harvested by
ultracentrifugation. The OMVs (∼1010 particles/mL)
are incubated on the coverslip surface before POPG and PEG are added
sequentially to induce rupturing and fusing of the vesicles and the
formation of a complete SLB. Naturally occurring membrane proteins
are colored yellow. (b) Three-dimensional AFM images depicting different
stages of the bilayer formation process (note that individual images
depict different samples): intact OMVs on the PLL-coated glass surface
before rupture (left) and an area of a partially formed bilayer (right).
The synthetic POPG bilayer can be seen on the left side of the image,
engulfing the OMVs and causing them to rupture. (c) FRAP data for
the OM-SLB, showing that the bleached circle (diameter of 30 μm)
recovers fluorescence over time. The diffusion coefficient (D) and mobile fraction (MF) values are 0.74 ± 0.14
μm2/s and 0.83 ± 0.06, respectively.
OM-SLB formation
and fluorescence microscopy analysis. (a) Schematic
showing the process of forming OM-SLBs on PLL-coated coverslips. OMVs
are produced naturally by E. coli and harvested by
ultracentrifugation. The OMVs (∼1010 particles/mL)
are incubated on the coverslip surface before POPG and PEG are added
sequentially to induce rupturing and fusing of the vesicles and the
formation of a complete SLB. Naturally occurring membrane proteins
are colored yellow. (b) Three-dimensional AFM images depicting different
stages of the bilayer formation process (note that individual images
depict different samples): intact OMVs on the PLL-coated glass surface
before rupture (left) and an area of a partially formed bilayer (right).
The synthetic POPG bilayer can be seen on the left side of the image,
engulfing the OMVs and causing them to rupture. (c) FRAP data for
the OM-SLB, showing that the bleached circle (diameter of 30 μm)
recovers fluorescence over time. The diffusion coefficient (D) and mobile fraction (MF) values are 0.74 ± 0.14
μm2/s and 0.83 ± 0.06, respectively.We used these OMVs to form SLBs on coverslips via vesicle
fusion,
as depicted in Figure a. Briefly, the negatively charged OMVs adhere to glass coated with
positively charged PLL. The OMVs are induced to rupture and fuse by
the addition of palmitoyloleoylphosphatidylglycerol (POPG) liposomes
followed by incubation at room temperature for 1 h. Bilayers made
of synthetic lipids form easily on the glass substrate, and then as
the edges of these bilayers approach and engulf the OMVs, these vesicles
rupture and fuse. The final stage is the addition of a PEG solution,
which aids in the bilayer formation process by inducing rupture of
any remaining vesicles through osmotic stress.[24] AFM imaging (Figure b) shows the vesicle fusion process taking place, where the
approaching edge of the synthetic bilayer induces the rupture of the
OMVs. Finally, the OMVs were stained with the fluorescent lipid-intercalating
dye octadecyl rhodamine-18 chloride (R18), and the presence of a complete
and mobile bilayer was confirmed by fluorescence recovery after photobleaching
(FRAP), as shown in Figure c. The two parameters used to quantify FRAP measurements are
the diffusion coefficient (D), which is the mean
squared displacement time of the diffusing lipids, and the mobile
fraction (MF), which is the proportion of mobile lipids in the bilayer.
For the OM-SLB, the D and MF values were 0.74 ± 0.14 μm2/s and 0.91 ± 0.06, respectively. These values are comparable
to those measured in previous studies of SLBs on glass and corroborate
the formation of a contiguous, mobile bilayer.[13]While confocal microscopy and FRAP characterization
of the bilayers
indicate the quality of the bilayers and enable quantification of
the lipid mobility, the limited resolution of the technique does not
allow for precise “mapping” of the synthetic and bacterial
components of the OM-SLBs. Such mapping would enable, for example,
quantification and optimization of the ratio of the natural to synthetic
fraction in the bilayer, quantification of the membrane protein content,
assessment of the distribution of the bacterial component within the
full bilayer, and direct visualization of membrane–protein
interactions.[25] To enable such mapping,
we used correlative AFM/SIM (Figure a) to sequentially visualize the same area with both
techniques, as described in the Experimental Section.
Figure 2
Correlative AFM/SIM imaging of a POPG SLB. (a) Simplified schematic
of the correlative AFM/SIM microscope setup. (bi) Correlative imaging
of a purely synthetic bilayer (POPG-SLB), formed by incubating 4 mg/mL
POPG on a PLL-coated coverslip (left). The lipids are stained with
R18 and visualized using SIM. (bii) The same area is imaged with AFM
highlighting the ability of correlative microscopy to access precisely
the same area of the bilayer. The bottom image shows a high-magnification
area of the bilayer (represented by the white box in the original
AFM image). The AFM height bar is 0–20 nm. (biii) Cross-sectional
height analysis of the high-magnification AFM image and schematic
representation of the POPG SLB formed on a glass substrate (not to
scale). The height of the SLB is measured at ∼4 nm.
Correlative AFM/SIM imaging of a POPG SLB. (a) Simplified schematic
of the correlative AFM/SIM microscope setup. (bi) Correlative imaging
of a purely synthetic bilayer (POPG-SLB), formed by incubating 4 mg/mL
POPG on a PLL-coated coverslip (left). The lipids are stained with
R18 and visualized using SIM. (bii) The same area is imaged with AFM
highlighting the ability of correlative microscopy to access precisely
the same area of the bilayer. The bottom image shows a high-magnification
area of the bilayer (represented by the white box in the original
AFM image). The AFM height bar is 0–20 nm. (biii) Cross-sectional
height analysis of the high-magnification AFM image and schematic
representation of the POPG SLB formed on a glass substrate (not to
scale). The height of the SLB is measured at ∼4 nm.We demonstrate the ability of the correlative system to image
the
same field of view using a POPG-only SLB sample, stained with R18
(Figure b). The edge
of the bilayer is imaged because the distinctive shape helps to register
the SIM and AFM images. Panels bi and bii of Figure show the same SLB region imaged using SIM
and AFM, respectively, and by zooming in on an area of the SLB with
AFM, we obtain a highly precise level of topographical information
about the bilayer, showing the bilayer to be smooth with few defects
as would be expected from a synthetic bilayer. Furthermore, by taking
five cross sections of ∼250 nm each of the SLB, we show that
the average height of the bilayer is 4.4 ± 0.3 nm, which corresponds
to the height of a synthetic lipid bilayer.[26,27]Having established the power of the correlative microscopy
method
to track precisely the same area of the bilayer, we move on to imaging
SLBs that contain OMVs as depicted in Figure . In this case, only the OMVs were stained
with R18, while the synthetic POPG lipids were unstained to enable
distinction of the two fractions (Figure ). When the resulting OM-SLB was assessed
with SIM, areas of high and low fluorescence were seen throughout
the bilayer, indicating diffusion of phospholipids between the two
fractions and demonstrating that the bilayer is complete and continuous.
Because the fluorescence from the R18 dye is present in both bilayer
regions even though only the OMVs were initially stained, we speculate
that this could be attributed to the ability of phospholipids to diffuse
between the two regions. The areas of high R18 fluorescence could
then arise due to the presence of lipopolysaccharide (LPS) in the
OM-SLB regions hindering R18 diffusion because the LPS in the outer
leaflet of the OM-SLB diffuses much more slowly, as has been suggested
by molecular dynamics simulations.[28] Therefore,
areas of high fluorescence were interpreted as originating from OMVs
and used as a beacon for the bacterial fraction within the bilayer.
Figure 3
Imaging
OM-SLBs using correlative AFM/SIM. (a) Correlative imaging
of an OM-SLB, formed in the same manner as depicted in Figure . (ai) The OMVs are stained
with R18, and the bilayer is imaged using SIM. (aii) The same area
is imaged with AFM. Two distinct regions can be seen in the bilayer:
a highly fluorescent region that corresponds to taller features in
the AFM image and one exhibiting lower fluorescence levels where corresponding
heights measured by AFM are ∼4 nm. (aiii) Cross-sectional height
analysis (an average of five representative cross sections taken)
shows the two regions of the bilayer correspond to heights of ∼4
and ∼9 nm. These represent the synthetic and bacterial component
regions of the bilayer, respectively, in line with bilayer heights
reported in the literature. The red line represents the threshold
value above which exists the bacterial component of the bilayer. (bi)
5 μm × 5 μm AFM image of the OMSLB. The white arrow
shows a representative section used for the cross sectional height
analysis. AFM heights are 0–20 nm. (bii) Corresponding three-dimensional
image that shows the areas of different heights corresponding to the
synthetic and bacterial component regions (top). Schematic showing
the bacterial and synthetic components of the bilayer, with the red
line depicting the threshold used to calculate the areas of bacterial
component as a proportion of total bilayer coverage (bottom). (biii)
Quantification of the bacterial component as a percentage of the entire
SLB imaging area. The box and whisker plot represents the following
percentiles: minimum, 25.3%; 25th percentile, 35.4%; 50th percentile,
39.9%; 75th percentile, 55.6%; maximum, 67.3%.
Imaging
OM-SLBs using correlative AFM/SIM. (a) Correlative imaging
of an OM-SLB, formed in the same manner as depicted in Figure . (ai) The OMVs are stained
with R18, and the bilayer is imaged using SIM. (aii) The same area
is imaged with AFM. Two distinct regions can be seen in the bilayer:
a highly fluorescent region that corresponds to taller features in
the AFM image and one exhibiting lower fluorescence levels where corresponding
heights measured by AFM are ∼4 nm. (aiii) Cross-sectional height
analysis (an average of five representative cross sections taken)
shows the two regions of the bilayer correspond to heights of ∼4
and ∼9 nm. These represent the synthetic and bacterial component
regions of the bilayer, respectively, in line with bilayer heights
reported in the literature. The red line represents the threshold
value above which exists the bacterial component of the bilayer. (bi)
5 μm × 5 μm AFM image of the OMSLB. The white arrow
shows a representative section used for the cross sectional height
analysis. AFM heights are 0–20 nm. (bii) Corresponding three-dimensional
image that shows the areas of different heights corresponding to the
synthetic and bacterial component regions (top). Schematic showing
the bacterial and synthetic components of the bilayer, with the red
line depicting the threshold used to calculate the areas of bacterial
component as a proportion of total bilayer coverage (bottom). (biii)
Quantification of the bacterial component as a percentage of the entire
SLB imaging area. The box and whisker plot represents the following
percentiles: minimum, 25.3%; 25th percentile, 35.4%; 50th percentile,
39.9%; 75th percentile, 55.6%; maximum, 67.3%.When the same area was imaged using AFM, we saw that the bilayer
was not smooth as was the case for the POPG bilayer, but there were
distinct bilayer regions with different heights that corresponded
to areas of low and high fluorescence. We postulate that the areas
of high fluorescence/height correspond to areas of OM from the E. coli cells while the low fluorescence/height regions
correspond to areas of POPG SLB. Because the bilayer formation process
is based on the synthetic bilayer forming first and then engulfing
OMVs, causing them to fuse and rupture to form bacterial membrane
patches, we hypothesize that the very high regions at the center of
these patches correspond to still unruptured OMVs. The size of each
bacterial patch is dependent on the number of OMVs that have been
fused together (Figure S7). On the basis
of this hypothesis, we quantified the area of the OM-SLB and POPG-SLB
patches within the hybrid SLBs in 10 different regions and showed
that the bacterial component covers 43 ± 14% of the total bilayer
area. A cross-sectional height analysis, performed on multiple areas
of the AFM images, revealed the lower height bilayer region, which
corresponded to areas of low fluorescence, to be 3.75 ± 0.27
nm, suggesting this is POPG SLB. The higher SLB patches, which corresponded
to areas of high fluorescence, were 8.75 ± 0.13 nm in height.
This height corresponds to the reported height of the OM in E. coli cells,[29] which is greater
than the height of a synthetic lipid bilayer, because of the presence
of lipopolysaccharides. The combination of SIM and AFM, therefore,
reveals that the hybrid SLB contains discrete patches of OM-SLB and
POPG-SLB. We theorize that this lack of mixing may be overcome by
the use of a cushioned substrate upon which to generate SLBs, such
as the conducting polymer PEDOT:PSS.One of the main strengths
of the OM-SLB platform is the potential
to easily express proteins of interest in the bacteria from which
the OMVs are derived and, therefore, have these proteins present in
the OMVs (Figure a).
We demonstrated this ability by expressing a lipoprotein–outer
membrane protein A–GFP binding nanobody (LppOmpA-GFP, hereafter
called the nanobody complex) that specifically binds GFP.[18] Using a GFP binding assay, we showed that the
nanobody complex was expressed in BL21(DE3) cells (Figure S3). We isolated OMVs from the engineered E.
coli cells as described above, with an extra rhamnose addition
step to induce the expression of the nanobody complex, and ran both
OMV types on an sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) gel to compare the protein content (Figure b). An extra protein band was
visible in the nanobody OMVs compared with the untransformed OMVs
and corresponded to the expected molecular weight of the nanobody
(∼28 kDa), indicating successful expression of the protein
of interest in the OMVs. By following the same SLB formation sequence
as in Figure a, we
used the nanobody OMVs to make OM-SLBs containing the nanobody complex.
FRAP confirmed the presence of a complete and mobile bilayer with
the SLB showing a diffusion coefficient of 0.94 ± 0.08 μm2/s and a mobile fraction of 0.86 ± 0.10 (Figure c).
Figure 4
(ai) Schematic showing
OMVs expressing the nanobody complex produced
from transformed E. coli cells. (aii) Schematic of
the OM-SLB formed using OMVs expressing the GFP binding nanobody complex.
(b) SDS–PAGE gel of untransformed and transformed OMVs. The
left lane shows the protein content of BL21(DE3) OMVs, while the right
lane shows the protein content of the LppOmpA-GFP nanobody complex-transformed
OMVs. A red arrow indicates the nanobody band, which has a molecular
weight of ∼28 kDa. (c) FRAP data for the OM–nanobody
SLB (diameter of bleached circle, 30 μm). The corresponding
FRAP parameters are D = 0.94 ± 0.08 μm2/s and MF = 0.86 ± 0.10 for this bilayer.
(ai) Schematic showing
OMVs expressing the nanobody complex produced
from transformed E. coli cells. (aii) Schematic of
the OM-SLB formed using OMVs expressing the GFP binding nanobody complex.
(b) SDS–PAGE gel of untransformed and transformed OMVs. The
left lane shows the protein content of BL21(DE3) OMVs, while the right
lane shows the protein content of the LppOmpA-GFP nanobody complex-transformed
OMVs. A red arrow indicates the nanobody band, which has a molecular
weight of ∼28 kDa. (c) FRAP data for the OM–nanobody
SLB (diameter of bleached circle, 30 μm). The corresponding
FRAP parameters are D = 0.94 ± 0.08 μm2/s and MF = 0.86 ± 0.10 for this bilayer.Having established that the bacterial membrane forms discrete
patches
within the hybrid SLB, we used correlative AFM/SIM to visualize the
localization of a specific protein within the bacterial component
of the SLBs. We generated standard OM-SLBs and OM-SLBs from bacteria
that expressed the nanobody complex (OM-NB SLB) and incubated both
with GFP (Figure a).
As seen previously, the OM-SLB shows two SLB regions of distinct height
differences (Figure b). These regions are also evident in the case of the nanobody containing
SLB, but crucially here the SIM reconstruction reveals the patches
of bacterial SLB fluoresce strongly in the 488 nm wavelength region
(Figure c), suggesting
the presence of bound GFP. Furthermore, the correlative AFM images
of the bilayers indicate the presence of surface features on the bacterial
component of the nanobody bilayer that are not present in the control
OM-SLB. This further confirms the existence of bacterial fractions
within the bilayer, as the GFP can bind only to the nanobody complex
that is present in the OMVs. A cross sectional analysis of the bacterial
component of the OM-SLBs shows a range of 1.42 nm compared to a range
of 6.01 nm for the OM-NB SLB (Figure di). A more in-depth analysis of the surface roughness
at the bacterial fractions of the SLBs (Figure dii) showed that the mean height of the surface
features in the OM NB-SLB with GFP bound was 4.85 nm (range of 2.95–6.74
nm), with this height corresponding to the reported length of a GFP
molecule.[30] By contrast, surface features
in the control OM-SLB had a mean height of only 1.94 nm (range of
0.94–4.20 nm), and although there are outlier points in the
OM-SLB roughness analysis, these likely reflect the presence of naturally
occurring outer membrane proteins. Additionally, we quantified the
difference in fluorescence between bacterial membrane patches that
contain the nanobody complex and those that do not by calculating
the corrected total green fluorescence (CTF) and showed that the average
CTF for the OM–nanobody SLB is approximately double that of
the OM-SLB (Figure dii) and that of a POPG SLB (Figure S4). The ability to map the bacterial component of the SLB using GFP
binding is a key finding, as it shows that we can identify areas of
interest in these complex systems using correlative AFM-SIM and quantify
binding events occurring on these membranes. Furthermore, we can manipulate
these systems precisely by altering the expression profile of the
bacterial component. This is particularly exciting when we consider
the future applications of this method, particularly with respect
to antimicrobial screening studies.[14] For
instance, if we wish to analyze the interaction of a certain class
of antibiotic with a protein target of interest in a bacterial membrane,
we can overexpress or indeed delete this protein from our membranes.
In this way, we have a platform for tailored pharmacological studies
in a reproducible and safe to use manner. Moreover, we can combine
microscopy with other in vitro techniques, such as
electrical impedance spectroscopy, to further investigate the pharmacological
profile of a given antimicrobial.
Figure 5
Schematic of (ai) OM-SLB and (aii) OM-SLB
expressing the GFP binding
nanobody complex in both cases after incubation with GFP. (bi) AFM
image of a 10 μm × 10 μm area of the OMSLB. (bii)
Corresponding reconstructed SIM image. (biii) 5 μm × 5
μm and (biv) 2 μm × 2 μm higher-magnification
three-dimensional (3D) images of the bacterial component of the SLB.
(ci) AFM image of a 10 μm × 10 μm area of the OM-NB
SLB. (cii) Corresponding reconstructed SIM image. (ciii) 5 μm
× 5 μm and (civ) 2 μm × 2 μm higher-magnification
3D images of the bacterial component of the OM-NB SLB. The height
bar for each AFM image is 0–20 nm. (di) Height profile for
a representative cross section of the OM-SLB vs OM-NB SLB, showing
the increased height range in the case of the GFP-bound SLB. (dii)
Surface roughness analysis for the OM and OM-NB SLBs after GFP incubation
(left). The average surface roughness in the OM-NB SLB case is 4.85
nm, compared to just 1.94 nm for the OM SLB case. GFP fluorescence
intensity signal for the OM-SLB vs the OM-NB SLB, showing the increase
in the intensity of the fluorescence signal for the nanobody SLB (right).
Schematic of (ai) OM-SLB and (aii) OM-SLB
expressing the GFP binding
nanobody complex in both cases after incubation with GFP. (bi) AFM
image of a 10 μm × 10 μm area of the OMSLB. (bii)
Corresponding reconstructed SIM image. (biii) 5 μm × 5
μm and (biv) 2 μm × 2 μm higher-magnification
three-dimensional (3D) images of the bacterial component of the SLB.
(ci) AFM image of a 10 μm × 10 μm area of the OM-NB
SLB. (cii) Corresponding reconstructed SIM image. (ciii) 5 μm
× 5 μm and (civ) 2 μm × 2 μm higher-magnification
3D images of the bacterial component of the OM-NB SLB. The height
bar for each AFM image is 0–20 nm. (di) Height profile for
a representative cross section of the OM-SLB vs OM-NB SLB, showing
the increased height range in the case of the GFP-bound SLB. (dii)
Surface roughness analysis for the OM and OM-NB SLBs after GFP incubation
(left). The average surface roughness in the OM-NB SLB case is 4.85
nm, compared to just 1.94 nm for the OM SLB case. GFP fluorescence
intensity signal for the OM-SLB vs the OM-NB SLB, showing the increase
in the intensity of the fluorescence signal for the nanobody SLB (right).
Conclusions
In conclusion, we present
here correlative AFM/SIM as a method
for accurate characterization of bacterial supported lipid bilayers
at the nanoscale. This approach enables not only the mapping and quantification
of the bacterial and synthetic components within those bilayers but
also the visualization of single proteins bound to those components.
Having access to detailed maps of the bacterial and synthetic components
of these bilayers enables optimization of these systems with respect
to the quality of the bilayers and the quantity of the bacterial fraction.
Our method has the potential to facilitate antimicrobial discovery
by enabling investigation of how antimicrobial drugs and drug delivery
vehicles, such as nanomaterials and bacteriophages, interact with
the bacterial membrane. In this study, we have optimized our method
for visualization of SLBs that contain bacterial membrane fractions,
but correlative AFM/SIM can be employed to characterize SLBs that
contain natural components derived from mammalian cells, plants, and
other organisms. Furthermore, the method can be adapted for a variety
of other applications, ranging from investigation of single-molecule
interactions to characterization of inorganic two-dimensional materials.
Authors: Han-Yuan Liu; Hannah Grant; Hung-Lun Hsu; Raya Sorkin; Filip Bošković; Gijs Wuite; Susan Daniel Journal: ACS Appl Mater Interfaces Date: 2017-10-09 Impact factor: 9.229
Authors: Alice Pyne; Marc-Philipp Pfeil; Isabel Bennett; Jascindra Ravi; Patrizia Iavicoli; Baptiste Lamarre; Anita Roethke; Santanu Ray; Haibo Jiang; Angelo Bella; Bernd Reisinger; Daniel Yin; Benjamin Little; Juan C Muñoz-García; Eleonora Cerasoli; Peter J Judge; Nilofar Faruqui; Luigi Calzolai; Andre Henrion; Glenn J Martyna; Chris R M Grovenor; Jason Crain; Bart W Hoogenboom; Anthony Watts; Maxim G Ryadnov Journal: Chem Sci Date: 2016-09-26 Impact factor: 9.825
Authors: Michael G Hanna; Ioanna Mela; Lei Wang; Robert M Henderson; Edwin R Chapman; J Michael Edwardson; Anjon Audhya Journal: J Biol Chem Date: 2015-11-06 Impact factor: 5.157